{"id":{"repo_id":"brazil-uff","oai_identifier":"oai:app.uff.br:1/19096"},"canonical_url":"https://search.dev.ndltd.org/etd/brazil-uff/oai:app.uff.br:1/19096","repository":{"repo_id":"brazil-uff","name":"Brazil UFF","base_url":"https://app.uff.br/oai/request"},"display":{"title":"Comparação da midríase medicamentosa obtida em pacientes diabéticos tipo 2 sem neuropatia e não-diabéticos","abstract":"Purpose: Evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1%, in type 2 diabetics and non-diabetic patients. Methods: A total of 60 patients (120 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and tropicamide 1% (group 0, n=30 type 2 diabetic patients, 60 eyes and group 1, n=30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. In both groups, pupil diameter was measured after 40 minutes of eyedrops instillation. Results: Mean age for the diabetic group was 62.27 years (SD = 8.61 years) and for the non-diabetic group was 56.57 years (SD = 17.28 years). There was no significant difference between both groups. (p = 0.18). Considering right eyes, mean pupil diameter was 8.47 mm in the diabetic group (SD = 0.86 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between both groups (p = 0.15). Considering left eyes, mean pupil diameter was 8.53 mm in the diabetic group (SD = 0.94 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between the two groups (p = 0.32). Conclusion: When the combination of phenylephrine 10% and tropicamide 1% is used, type 2 diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment.","abstract_html":"Purpose: Evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1%, in type 2 diabetics and non-diabetic patients. Methods: A total of 60 patients (120 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and tropicamide 1% (group 0, n=30 type 2 diabetic patients, 60 eyes and group 1, n=30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. In both groups, pupil diameter was measured after 40 minutes of eyedrops instillation. Results: Mean age for the diabetic group was 62.27 years (SD = 8.61 years) and for the non-diabetic group was 56.57 years (SD = 17.28 years). There was no significant difference between both groups. (p = 0.18). Considering right eyes, mean pupil diameter was 8.47 mm in the diabetic group (SD = 0.86 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between both groups (p = 0.15). Considering left eyes, mean pupil diameter was 8.53 mm in the diabetic group (SD = 0.94 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between the two groups (p = 0.32). Conclusion: When the combination of phenylephrine 10% and tropicamide 1% is used, type 2 diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment.","abstract_has_math":false,"creators":["Coblentz, Jacqueline"],"institution":"Programa de Pós-graduação em Ciências Médicas","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010-12-28","date_published":"2010-12-28","updated_at":"2026-07-27T19:00:41Z","subjects":["Diabetes mellitus","Retinopatia diabética","Agentes midriáticos","Diâmetro pupilar","MEDICINA","CIÊNCIAS MÉDICAS","Midríase","Fenilefrina","Tropicamida","Diabetic retinopathy","Mydriatic drugs","Pupil diameter"],"languages":["por"],"rights":["Acesso Aberto"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://app.uff.br/riuff/handle/1/19096","outbound_label":"Repository record","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Coblentz, Jacqueline"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2021-03-10T20:46:28Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2011-03-21","2021-03-10T20:46:28Z"]},{"key":"dc:date.issued","label":"Date","values":["2010-12-28"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Ciências Médicas"]},{"key":"dc:type","label":"Dc Type","values":["Dissertação"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Diabetes mellitus","Retinopatia diabética","Agentes midriáticos","Diâmetro pupilar","MEDICINA","CIÊNCIAS MÉDICAS","Midríase","Fenilefrina","Tropicamida","Diabetic retinopathy","Mydriatic drugs","Pupil diameter"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["por"]},{"key":"dc:rights","label":"Dc Rights","values":["Acesso Aberto"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://app.uff.br/riuff/handle/1/19096"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Purpose: Evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1%, in type 2 diabetics and non-diabetic patients. Methods: A total of 60 patients (120 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and tropicamide 1% (group 0, n=30 type 2 diabetic patients, 60 eyes and group 1, n=30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. In both groups, pupil diameter was measured after 40 minutes of eyedrops instillation. Results: Mean age for the diabetic group was 62.27 years (SD = 8.61 years) and for the non-diabetic group was 56.57 years (SD = 17.28 years). There was no significant difference between both groups. (p = 0.18). Considering right eyes, mean pupil diameter was 8.47 mm in the diabetic group (SD = 0.86 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between both groups (p = 0.15). Considering left eyes, mean pupil diameter was 8.53 mm in the diabetic group (SD = 0.94 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between the two groups (p = 0.32). Conclusion: When the combination of phenylephrine 10% and tropicamide 1% is used, type 2 diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Comparação da midríase medicamentosa obtida em pacientes diabéticos tipo 2 sem neuropatia e não-diabéticos"]}]}],"canonical_facts":{"dc:creator":["Coblentz, Jacqueline"],"dc:date.accessioned":["2021-03-10T20:46:28Z"],"dc:date.available":["2011-03-21","2021-03-10T20:46:28Z"],"dc:date.issued":["2010-12-28"],"dc:description.abstract":["Purpose: Evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1%, in type 2 diabetics and non-diabetic patients. Methods: A total of 60 patients (120 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and tropicamide 1% (group 0, n=30 type 2 diabetic patients, 60 eyes and group 1, n=30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. In both groups, pupil diameter was measured after 40 minutes of eyedrops instillation. Results: Mean age for the diabetic group was 62.27 years (SD = 8.61 years) and for the non-diabetic group was 56.57 years (SD = 17.28 years). There was no significant difference between both groups. (p = 0.18). Considering right eyes, mean pupil diameter was 8.47 mm in the diabetic group (SD = 0.86 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between both groups (p = 0.15). Considering left eyes, mean pupil diameter was 8.53 mm in the diabetic group (SD = 0.94 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between the two groups (p = 0.32). Conclusion: When the combination of phenylephrine 10% and tropicamide 1% is used, type 2 diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment."],"dc:format":["application/pdf"],"dc:identifier.uri":["https://app.uff.br/riuff/handle/1/19096"],"dc:language":["por"],"dc:publisher.department":["Ciências Médicas"],"dc:rights":["Acesso Aberto"],"dc:subject":["Diabetes mellitus","Retinopatia diabética","Agentes midriáticos","Diâmetro pupilar","MEDICINA","CIÊNCIAS MÉDICAS","Midríase","Fenilefrina","Tropicamida","Diabetic retinopathy","Mydriatic drugs","Pupil diameter"],"dc:title":["Comparação da midríase medicamentosa obtida em pacientes diabéticos tipo 2 sem neuropatia e não-diabéticos"],"dc:type":["Dissertação"]},"updated_at":"2026-07-27T19:00:41Z"}